Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Interleukin-13 disrupts type 2 pneumocyte stem cell activity
Kristen M. Glisinski, Adam J. Schlobohm, Sarah V. Paramore, Anastasiya Birukova, M. Arthur Moseley, Matthew W. Foster, Christina E. Barkauskas
Kristen M. Glisinski, Adam J. Schlobohm, Sarah V. Paramore, Anastasiya Birukova, M. Arthur Moseley, Matthew W. Foster, Christina E. Barkauskas
View: Text | PDF
Research Article Pulmonology Stem cells

Interleukin-13 disrupts type 2 pneumocyte stem cell activity

  • Text
  • PDF
Abstract

The T helper 2 (Th2) inflammatory cytokine interleukin-13 (IL-13) has been associated with both obstructive and fibrotic lung diseases; however, its specific effect on the epithelial stem cells in the gas exchange compartment of the lung (alveolar space) has not been explored. Here, we used in vivo lung models of homeostasis and repair, ex vivo organoid platforms, and potentially novel quantitative proteomic techniques to show that IL-13 disrupts the self-renewal and differentiation of both murine and human type 2 alveolar epithelial cells (AEC2s). Significantly, we find that IL-13 promotes ectopic expression of markers typically associated with bronchiolar airway cells and commonly seen in the alveolar region of lung tissue from patients with idiopathic pulmonary fibrosis. Furthermore, we identify a number of proteins that are differentially secreted by AEC2s in response to IL-13 and may provide biomarkers to identify subsets of patients with pulmonary disease driven by “Th2-high” biology.

Authors

Kristen M. Glisinski, Adam J. Schlobohm, Sarah V. Paramore, Anastasiya Birukova, M. Arthur Moseley, Matthew W. Foster, Christina E. Barkauskas

×

Figure 1

IL-13 overexpression leads to an increase in the proportion of AEC2s to AEC1s.

Options: View larger image (or click on image) Download as PowerPoint
IL-13 overexpression leads to an increase in the proportion of AEC2s to ...
(A) Constitutive overexpression of IL-13 from airway epithelial cells in the Scgb1a1-Il-13–transgenic mouse leads to airspace enlargement and a proportional increase in the number of AEC2s (labeled with DC-LAMP [LAMP3]) compared with AEC1s (marked by podoplanin [PDPN] expression). (B) The proportion of AEC2s to AEC1s was assessed by counting AEC2s (DC-LAMP+ cells) and AEC1s (cells with nuclear expression of homeobox only protein X, HOPX) and expressing the results as a proportion (AEC2/AEC1). There are more AEC2s relative to AEC1s in the IL-13–overexpressing mice. Unpaired t test; error bars indicate mean ± SD. (C) Schematic for lineage-labeling AEC2s in adult mice with (SftpcTmIL13) and without (SftpcTm) constitutive overexpression of IL-13 and subsequent pneumonectomy procedure (PNX). (D) Control lungs 14 days after PNX contain many lineage-labeled AEC1s. (E) IL-13–overexpressing lungs (IL-13 PNX) contain fewer lineage-labeled AEC1s after PNX when compared with controls (control PNX) despite higher levels of post-PNX AEC2 proliferation (data not shown and Supplemental Figure 1). Unpaired t test; error bars indicate mean ± SD. Scale bars: 100 μm (A), 75 μm (D). **P < 0.005.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts